[Retracted] Influence of Dexmedetomidine on Myocardial Injury in Patients with Simultaneous Pancreas-Kidney Transplantation

Table 3

Changes in myocardial injury biomarkers at every time point.

Variables	Control group		Dex group
	cTnI (μg/L)	CK-MB (μg/L)	cTnI (μg/L)	CK-MB (μg/L)
T0	0.05 ± 0.01	1.64 ± 0.30	0.05 ± 0.01	1.65 ± 0.32
T1	0.06 ± 0.00^#	1.99 ± 0.37^#	0.05 ± 0.01^#	2.04 ± 0.37^#
T2	0.20 ± 0.03^#	5.74 ± 0.39^#	0.09 ± 0.01^#	3.25 ± 0.49^#
T3	0.32 ± 0.02^#	7.76 ± 0.35^#	0.17 ± 0.01^#	4.84 ± 0.29^#
T4	4.84 ± 0.29^#	10.88 ± 0.49^#	0.32 ± 0.04^#	7.35 ± 0.32^#
T5	0.50 ± 0.01^#	9.50 ± 0.55^#	0.17 ± 0.01^#	5.88 ± 0.30^#
T6	0.43 ± 0.01^#	7.46 ± 0.33^#	0.17 ± 0.01^#	4.61 ± 0.18^#

Values are presented as mean ± SD. T0: 5 minutes after anaesthesia induction; T1: 5 minutes before renal arteriovenous opening; T2: 30 minutes after renal arteriovenous opening; T3: 30 minutes after pancreatic related arteriovenous opening; T4: immediately after surgery; T5: 4 hours after surgery; T6: 24 hours after surgery. compared with C group, ^# compared with T0. cTnI, cardiac troponin I; CK-MB, creatine kinase isoenzyme.